Vuzix [VUZI] vs Zepp Health [ZEPP] Detailed Stock Comparison
Vuzix
NASDAQ
Loading...
Zepp Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Vuzix wins in 2 metrics, Zepp Health wins in 16 metrics, with 0 ties. Zepp Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vuzix | Zepp Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.80 | -2.80 | Zepp Health |
| Price-to-Book Ratio | 4.50 | 0.81 | Zepp Health |
| Debt-to-Equity Ratio | 1.09 | 46.23 | Vuzix |
| PEG Ratio | -4.62 | -1,300.00 | Zepp Health |
| EV/EBITDA | -3.41 | -66.54 | Zepp Health |
| Profit Margin (TTM) | -97.31% | -44.54% | Zepp Health |
| Operating Margin (TTM) | -556.18% | -47.68% | Zepp Health |
| Return on Equity | -136.11% | -28.56% | Zepp Health |
| Return on Assets (TTM) | -46.89% | -5.65% | Zepp Health |
| Free Cash Flow (TTM) | $-26.66M | $-25.88M | Zepp Health |
| 1-Year Return | 71.68% | 507.48% | Zepp Health |
| Price-to-Sales Ratio (TTM) | 27.74 | 1.03 | Zepp Health |
| Enterprise Value | $133.04M | $3.02B | Zepp Health |
| EV/Revenue Ratio | 24.95 | 16.66 | Zepp Health |
| Gross Profit Margin (TTM) | -16.77% | 37.27% | Zepp Health |
| Revenue per Share (TTM) | $0 | $11 | Zepp Health |
| Earnings per Share (Diluted) | $-1.03 | $-4.96 | Vuzix |
| Beta (Stock Volatility) | 1.64 | 0.85 | Zepp Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vuzix vs Zepp Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vuzix | -3.48% | -14.54% | -28.68% | 2.11% | -54.35% | -53.14% |
| Zepp Health | -3.42% | 16.80% | 360.99% | 381.48% | 357.75% | 352.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vuzix | 71.68% | -77.28% | -51.50% | -57.36% | -76.48% | -84.78% |
| Zepp Health | 507.48% | 92.31% | -71.37% | -71.44% | -71.44% | -71.44% |
Performance & Financial Health Analysis: Vuzix vs Zepp Health
| Metric | VUZI | ZEPP |
|---|---|---|
| Market Information | ||
| Market Cap | $147.91M | $186.79M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 1,354,110 | 297,500 |
| 90 Day Avg. Volume | 1,725,107 | 1,000,603 |
| Last Close | $1.94 | $13.00 |
| 52 Week Range | $0.83 - $5.79 | $2.06 - $15.85 |
| % from 52W High | -66.49% | -17.98% |
| All-Time High | $32.43 (Apr 05, 2021) | $81.00 (Feb 15, 2021) |
| % from All-Time High | -94.02% | -83.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.21% | -0.03% |
| Quarterly Earnings Growth | -0.21% | 5.89% |
| Financial Health | ||
| Profit Margin (TTM) | -0.97% | -0.45% |
| Operating Margin (TTM) | -5.56% | -0.48% |
| Return on Equity (TTM) | -1.36% | -0.29% |
| Debt to Equity (MRQ) | 1.09 | 46.23 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.43 | $16.15 |
| Cash per Share (MRQ) | $0.20 | $0.34 |
| Operating Cash Flow (TTM) | $-18,387,856 | $-25,970,000 |
| Levered Free Cash Flow (TTM) | $-4,699,632 | $-137,800,733 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Vuzix vs Zepp Health
| Metric | VUZI | ZEPP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.80 | -2.80 |
| Forward P/E | -4.62 | -1,300.00 |
| PEG Ratio | -4.62 | -1,300.00 |
| Price to Sales (TTM) | 27.74 | 1.03 |
| Price to Book (MRQ) | 4.50 | 0.81 |
| Market Capitalization | ||
| Market Capitalization | $147.91M | $186.79M |
| Enterprise Value | $133.04M | $3.02B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 24.95 | 16.66 |
| Enterprise to EBITDA | -3.41 | -66.54 |
| Risk & Other Metrics | ||
| Beta | 1.64 | 0.85 |
| Book Value per Share (MRQ) | $0.43 | $16.15 |
Financial Statements Comparison: Vuzix vs Zepp Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VUZI | ZEPP |
|---|---|---|
| Revenue/Sales | $1.58M | $38.54M |
| Cost of Goods Sold | $1.85M | $24.18M |
| Gross Profit | $-265,118 | $14.36M |
| Research & Development | $2.61M | $12.38M |
| Operating Income (EBIT) | $-8.79M | $-18.38M |
| EBITDA | $-8.32M | $-17.79M |
| Pre-Tax Income | $-8.64M | $-19.27M |
| Income Tax | $0 | $110,000 |
| Net Income (Profit) | $-8.64M | $-19.74M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VUZI | ZEPP |
|---|---|---|
| Cash & Equivalents | $15.23M | $76.43M |
| Total Current Assets | $22.39M | $242.46M |
| Total Current Liabilities | $2.92M | $212.34M |
| Long-Term Debt | N/A | $71.16M |
| Total Shareholders Equity | $32.85M | $232.04M |
| Retained Earnings | $-376.16M | $8.88M |
| Property, Plant & Equipment | $9.89M | $9.56M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VUZI | ZEPP |
|---|---|---|
| Operating Cash Flow | $-3.03M | $-14.63M |
| Capital Expenditures | $-613,397 | $-2.92M |
| Free Cash Flow | $-4.17M | $-16.89M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VUZI | ZEPP |
|---|---|---|
| Shares Short | 18.23M | 308,546 |
| Short Ratio | 9.82 | 0.25 |
| Short % of Float | 0.26% | 0.05% |
| Average Daily Volume (10 Day) | 1,354,110 | 297,500 |
| Average Daily Volume (90 Day) | 1,725,107 | 1,000,603 |
| Shares Outstanding | 75.97M | 231.98M |
| Float Shares | 63.75M | 98.58M |
| % Held by Insiders | 0.17% | 0.06% |
| % Held by Institutions | 0.22% | 0.26% |
Dividend Analysis & Yield Comparison: Vuzix vs Zepp Health
| Metric | VUZI | ZEPP |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |